| Literature DB >> 35256011 |
Yanan Wang1, Zhipeng Yang1, Yuanfei Zhou1, Jiajian Tan2, Haiqing Sun2, Defa Sun3, Yuyun Mu3, Jian Peng1,4, Hongkui Wei5,6.
Abstract
BACKGROUND: Over the past years, antibiotic growth promoter had been restricted in animal husbandry production in many countries because of antimicrobial resistance and foodborne antibiotic residues. However, the problems of poor intestinal health and low growth efficiency of piglets have not been solved completely in an antibiotic-free diet, and it is urgent to explore alternatives to antimicrobial growth promoters.Entities:
Keywords: Amino acids; Antioxidant capacity; Carvacrol and thymol; Intestinal health; Plant extracts; Weaned pigs
Year: 2022 PMID: 35256011 PMCID: PMC8903733 DOI: 10.1186/s40104-022-00674-7
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Ingredients and nutrient composition of diet during 1 ~ 14 d
| Composition, % | Low AA | High AA | ||
|---|---|---|---|---|
| CB(−) | CB(+) | CB(−) | CB(+) | |
| Prepuffed raw materials | 53.08 | 53.03 | 54.16 | 54.11 |
| Fermented soybean meal | 8.90 | 8.90 | 7.40 | 7.40 |
| Yeast | 2.08 | 2.08 | 2.08 | 2.08 |
| Fermented products | 6.67 | 6.67 | 6.67 | 6.67 |
| Low protein whey powder | 12.50 | 12.50 | 12.50 | 12.50 |
| High protein whey powder | 2.78 | 2.78 | 2.78 | 2.78 |
| Glucose | 2.78 | 2.78 | 2.78 | 2.78 |
| Sucrose | 2.50 | 2.50 | 2.50 | 2.50 |
| Soybean oil | 2.60 | 2.60 | 2.30 | 2.30 |
| Phospholipid powder | 1.50 | 1.50 | 1.50 | 1.50 |
| Limestone | 0.29 | 0.29 | 0.29 | 0.29 |
| Dicalcium phosphate | 0.67 | 0.67 | 0.69 | 0.69 |
| Sodium chloride | 0.23 | 0.23 | 0.23 | 0.23 |
| Lysine, 98% | 0.57 | 0.57 | 0.8 | 0.8 |
| Methionine | 0.25 | 0.25 | 0.35 | 0.35 |
| Threonine | 0.31 | 0.31 | 0.42 | 0.42 |
| Tryptophan | 0.10 | 0.10 | 0.14 | 0.14 |
| Valine | 0.18 | 0.18 | 0.30 | 0.30 |
| Isoleucine | 0.09 | 0.09 | 0.19 | 0.19 |
| ZnO | 0.20 | 0.20 | 0.20 | 0.20 |
| Activate® DA | 0.50 | 0.50 | 0.50 | 0.50 |
| Montmorillonite | 0.40 | 0.40 | 0.40 | 0.40 |
| Feed antifungal agent | 0.05 | 0.05 | 0.05 | 0.05 |
| Choline chloride | 0.12 | 0.12 | 0.12 | 0.12 |
| Food attractant | 0.05 | 0.05 | 0.05 | 0.05 |
| Premix* | 0.60 | 0.60 | 0.60 | 0.60 |
| Carvacrol and thymol | 0.05 | 0.05 | ||
| Total | 100 | 100 | 100 | 100 |
| Nutrient content | ||||
| Digestible energy, kcal/kg | 3463.00 | 3463.00 | 3458.60 | 3458.60 |
| Crude protein, % | 18.00 | 18.00 | 17.98 | 17.98 |
| Digestible lysine, % | 1.35 | 1.35 | 1.50 | 1.50 |
| Digestible methionine, % | 0.62 | 0.62 | 0.71 | 0.71 |
| Digestible threonine, % | 0.88 | 0.88 | 0.97 | 0.97 |
| Digestible tryptophan, % | 0.27 | 0.27 | 0.30 | 0.30 |
| Digestible valine, % | 0.87 | 0.87 | 0.96 | 0.96 |
| Ca, % | 0.50 | 0.50 | 0.49 | 0.49 |
| Available P, % | 0.36 | 0.36 | 0.36 | 0.36 |
*Provided per kg of diet: Vitamin E 200 mg, Vitamin C 350 mg, piglet multidimensional 350 mg, piglet micromine 3000 mg, protein enzyme (Cibenza® DP100) 100 mg, phytase 200 mg, microecological preparations 300 mg, antiseptic 1000 mg, antioxidants 200 mg, flavour 800 mg, sweetener 300 mg, sodium butyrate 1500 mg
Ingredients and nutrient composition of diet during 15 ~ 42 d
| Composition, % | Low AA | High AA | ||
|---|---|---|---|---|
| CB (−) | CB(+) | CB(−) | CB(+) | |
| Corn | 30.40 | 30.35 | 31.40 | 31.35 |
| Prepuffed raw materials | 33.04 | 33.04 | 32.99 | 32.99 |
| Pretreatment raw materials | 7.00 | 7.00 | 7.00 | 7.00 |
| Soybean meal, 46% CP | 5.40 | 5.40 | 4.00 | 4.00 |
| Fermented soybean meal | 8.00 | 8.00 | 8.00 | 8.00 |
| Brewer’s yeast hydrolysate | 1.39 | 1.39 | 1.39 | 1.39 |
| Low protein whey powder | 5.56 | 5.56 | 5.56 | 5.56 |
| High protein whey powder | 1.39 | 1.39 | 1.39 | 1.39 |
| Cheese whey | 0.69 | 0.69 | 0.69 | 0.69 |
| Soybean oil | 1.90 | 1.90 | 1.60 | 1.60 |
| Phospholipid powder | 0.50 | 0.50 | 0.50 | 0.50 |
| Limestone | 0.80 | 0.80 | 0.80 | 0.80 |
| Dicalcium phosphate | 0.82 | 0.82 | 0.84 | 0.84 |
| Sodium chloride | 0.39 | 0.39 | 0.39 | 0.39 |
| Lysine, 98% | 0.58 | 0.58 | 0.82 | 0.82 |
| Methionine | 0.17 | 0.17 | 0.27 | 0.27 |
| Threonine | 0.26 | 0.26 | 0.38 | 0.38 |
| Tryptophan | 0.08 | 0.08 | 0.12 | 0.12 |
| Valine | 0.13 | 0.13 | 0.25 | 0.25 |
| Isoleucine | 0.03 | 0.03 | 0.14 | 0.14 |
| Feed antifungal agent | 0.05 | 0.05 | 0.05 | 0.05 |
| Montmorillonite | 0.40 | 0.40 | 0.40 | 0.40 |
| Choline chloride | 0.1 | 0.1 | 0.1 | 0.1 |
| Food attractant | 0.05 | 0.05 | 0.05 | 0.05 |
| Activate® DA | 0.27 | 0.27 | 0.27 | 0.27 |
| Premix * | 0.60 | 0.60 | 0.60 | 0.60 |
| Carvacrol and thymol | 0.05 | 0.05 | ||
| Total | 100 | 100 | 100 | 100 |
| Nutrient content | ||||
| Digestible energy, kcal/kg | 3427.70 | 3427.70 | 3425.10 | 3425.10 |
| Crude protein, % | 17.99 | 17.99 | 17.98 | 17.98 |
| Digestible lysine, % | 1.25 | 1.25 | 1.40 | 1.40 |
| Digestible methionine, % | 0.49 | 0.49 | 0.58 | 0.58 |
| Digestible threonine, % | 0.81 | 0.81 | 0.91 | 0.91 |
| Digestible tryptophan, % | 0.25 | 0.25 | 0.28 | 0.28 |
| Digestible valine, % | 0.83 | 0.83 | 0.92 | 0.92 |
| Ca, % | 0.60 | 0.60 | 0.59 | 0.59 |
| Available P, % | 0.34 | 0.34 | 0.34 | 0.34 |
*Provided per kg of diet: Vitamin E 200 mg, Vitamin C 350 mg, piglet multidimensional 350 mg, piglet micromine 3000 mg, protein enzyme (Cibenza® DP100) 100 mg, phytase 200 mg, microecological preparations 300 mg, antiseptic 1000 mg, antioxidants 200 mg, flavour 800 mg, sweetener 300 mg, sodium butyrate 1500 mg
Primers used for absolute quantitative real-time polymerase chain reaction (PCR)
| Target group | Sequence of primers, 5′ to 3′ | Size, bp |
|---|---|---|
| Total bacteria | Forward: GTGSTGCAYGGYYGTCGTCA | 146 |
| Reverse: ACGTCRTCCMCNCCTTCCTC | ||
| Forward: AGCAGTAGGGAATCTTCCA | 341 | |
| Reverse: CACCGCTACACATGGAG | ||
| Forward: CCCTTATTGTTAGTTGCCATCATT | 144 | |
| Reverse: ACTCGTTGTACTTCCCATTGT | ||
| Forward: CATGCCGCGTGTATGAAGAA | 96 | |
| Reverse: CGGGTAACGTCAATGAGCAAA | ||
| Forward: TCGCGTCTGGTGTGAAAG | 243 | |
| Reverse: CCACA TCCAGCATCCAC |
Growth performance of piglets
| Items | Low AA | High AA | SEM | |||||
|---|---|---|---|---|---|---|---|---|
| CB (−) | CB(+) | CB(−) | CB(+) | AA | CB | AA×CB | ||
| Number of pens | 5 | 5 | 4 | 5 | ||||
| 1 d BW, kg | 7.74 | 7.75 | 7.74 | 7.77 | 0.01 | 0.60 | 0.40 | 0.91 |
| 14 d BW, kg | 10.85 | 11.29 | 11.07 | 11.56 | 0.09 | 0.14 | < 0.01 | 0.87 |
| 42 d BW, kg | 29.38 | 29.34 | 28.87 | 29.14 | 0.32 | 0.56 | 0.85 | 0.80 |
| 1 | ||||||||
| ADG, g/d | 226.49 | 255.57 | 236.61 | 268.09 | 6.33 | 0.32 | 0.01 | 0.91 |
| ADFI, g/d | 340.91 | 372.02 | 311.59 | 343.63 | 8.41 | 0.04 | 0.03 | 0.97 |
| ADLysI, g/d | 4.60 | 5.02 | 4.67 | 5.15 | 0.10 | 0.58 | 0.02 | 0.87 |
| FCR | 1.51 | 1.46 | 1.32 | 1.29 | 0.03 | < 0.01 | 0.31 | 0.91 |
| Diarrhea rate, % | 7.31 a | 5.78 ab | 5.51 ab | 5.24 b | 0.47 | 0.03 | 0.07 | 0.03 |
| Diarrhea index | 0.18 ± 0.04 | 0.15 | 0.13 | 0.12 | 0.01 | 0.09 | 0.64 | 0.46 |
| 15 | ||||||||
| ADG, g/d | 657.21 | 642.87 | 632.62 | 628.98 | 8.28 | 0.28 | 0.61 | 0.76 |
| ADFI, g/d | 899.44 | 905.25 | 899.84 | 888.96 | 16.46 | 0.82 | 0.94 | 0.81 |
| ADLysI, g/d | 11.24 | 11.32 | 12.6 | 12.45 | 0.25 | 0.01 | 0.93 | 0.80 |
| FCR | 1.37 | 1.41 | 1.42 | 1.41 | 0.01 | 0.98 | 0.72 | 0.39 |
| 1 | ||||||||
| ADG, g/d | 515.35 | 514.56 | 501.96 | 508.79 | 6.47 | 0.50 | 0.83 | 0.79 |
| ADFI, g/d | 713.27 | 727.51 | 703.76 | 707.19 | 12.92 | 0.57 | 0.74 | 0.84 |
| ADLysI, g/d | 7.92 | 8.17 | 8.64 | 8.80 | 0.15 | 0.03 | 0.48 | 0.89 |
| FCR | 1.38 | 1.41 | 1.40 | 1.39 | 0.01 | 0.98 | 0.72 | 0.39 |
All results are presented as mean ± SEM. AA Amino acid effect, CB a carvacrol–thymol blend effect, AA×CB interaction effect of amino acid and a carvacrol–thymol blend, ADLysI average daily lysine intake. P < 0.05 significant difference, P < 0.01 extremely significant difference
Fig. 1Plasma urea nitrogen content in piglets. All results are presented as mean ± SEM (n = 8–10/group). AA: Amino acid effect; CB: a carvacrol–thymol blend effect, AA×CB: interaction effect of amino acid and a carvacrol–thymol blend. P < 0.05 significant difference, P < 0.01 extremely significant difference
Antioxidant enzyme activity and MDA content in plasma of piglets
| Times | Items | Low AA | High AA | SEM | |||||
|---|---|---|---|---|---|---|---|---|---|
| CB (−) | CB (+) | CB (−) | CB (+) | AA | CB | AA×CB | |||
| Number of pens | 10 | 10 | 8 | 10 | |||||
| 7 d | T-SOD, U/mL | 25.94 | 37.39 | 33.18 | 40.07 | 1.83 | 0.15 | 0.01 | 0.50 |
| GSH-px, μmol/L | 1023.54 | 992.86 | 998.93 | 935.54 | 20.77 | 0.34 | 0.27 | 0.70 | |
| MDA, nmol/mL | 6.96 | 5.81 | 7.33 | 6.52 | 0.24 | 0.26 | 0.04 | 0.72 | |
| T-AOC, U/mL | 0.76 | 0.75 | 0.75 | 0.79 | 0.01 | 0.38 | 0.59 | 0.12 | |
| 14 d | T-SOD, U/mL | 42.37 | 38.33 | 35.58 | 37.69 | 1.28 | 0.16 | 0.71 | 0.24 |
| GSH-px, μmol/L | 576.94 | 644.94 | 610.51 | 694.28 | 16.94 | 0.20 | 0.02 | 0.81 | |
| MDA, nmol/mL | 7.35 | 5.52 | 7.52 | 6.77 | 0.27 | 0.17 | 0.02 | 0.30 | |
| T-AOC, U/mL | 0.71 | 0.71 | 0.71 | 0.7 | 0.01 | 1.00 | 0.33 | 0.83 | |
All results are presented as mean ± SEM. AA Amino acid effect, CB a carvacrol–thymol blend effect, AA×CB interaction effect of amino acid and a carvacrol–thymol blend. P < 0.05 significant difference, P < 0.01 extremely significant difference
Fig. 2Effects of different treatments on inflammatory factors in piglets. A The content of TNF-α in plasma; B the content of IL-1β in plasma; C the content of IL-6 in plasma; D the content of IL-8 in plasma; E the content of Lipocalcin-2 in fecal. All results are presented as mean ± SEM (n = 8–10/group). AA: Amino acid effect; CB: a carvacrol–thymol blend, AA×CB: interaction effect of amino acid and a carvacrol–thymol blend. P < 0.05 significant difference, P < 0.01 extremely significant difference
Fig. 3Effects of different treatments on specific microorganisms in piglet feces. Relative abundance of A E. coli, B Enterococcus, C Lactobacillus and D Bifidobacterium in piglet feces. All results are presented as mean ± SEM (n = 8–10/group). AA: Amino acid effect; CB: a carvacrol–thymol blend effect, AA×CB: interaction effect of amino acid and a carvacrol–thymol blend. P < 0.1 indicates the tendency of significant difference, P < 0.05 significant difference
Fig. 4Concentrations of SCFAs in piglet feces. A The content of SCFAs in feces of piglets on d 7 after weaning; B the content of SCFAs in feces of piglets on d 14 after weaning. All results are presented as mean ± SEM (n = 8–10/group). AA: Amino acid effect; CB: a carvacrol–thymol blend effect, AA×CB: interaction effect of amino acid and a carvacrol–thymol blend. P < 0.1 indicates the tendency of significant difference
Fig. 5Effects of different treatments on intestinal barrier function in piglets. A The content of endotoxin in plasma; B the content of D-lactic acid in plasma; C the content of DAO in plasma; D the content of secretory immunoglobulin A content in fecal; E the content of MUC 2 in fecal. All results are presented as mean ± SEM (n = 8–10/group). AA: Amino acid effect; CB: a carvacrol–thymol blend effect, AA×CB: interaction effect of amino acid and a carvacrol–thymol blend. P < 0.1 indicates the tendency of significant difference, P < 0.05 significant difference, P < 0.01 extremely significant difference